Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study.
Saved in:
| Title: | Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study. |
|---|---|
| Authors: | Charbonnel, Bernard H.1 (AUTHOR) bernard.charbonnel@univ-nantes.fr, Chen, Hungta2 (AUTHOR), Cid‐Ruzafa, Javier3 (AUTHOR), Cooper, Andrew4 (AUTHOR), Fenici, Peter5 (AUTHOR), Gomes, Marilia B.6 (AUTHOR), Saraiva, Gabriela L.2 (AUTHOR), Medina, Jesús7 (AUTHOR), Nicolucci, Antonio8 (AUTHOR), Shestakova, Marina V.9 (AUTHOR), Shimomura, Iichiro10 (AUTHOR), Surmont, Filip11 (AUTHOR), Tang, Fengming12 (AUTHOR), Vora, Jiten13 (AUTHOR), Watada, Hirotaka14 (AUTHOR), Khunti, Kamlesh15 (AUTHOR) |
| Source: | Diabetes, Obesity & Metabolism. Jan2023, Vol. 25 Issue 1, p46-55. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
